-+ 0.00%
-+ 0.00%
-+ 0.00%
Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".
Share
Listen to the news

https://x.com/PatentGrants/status/2090166066538512778

https://patentcenter.uspto.gov/applications/18767226/ifw/docs

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending